Existing since October 2016, AHSF focuses on improving the quality of life of vulnerable population across communities in North East Nigeria. AHSF operates both in emergency and developmental context and have its program principally rooted in identifying gaps that affects population or increases vulnerability of population and bridging those gaps through resource base planning and implementation.
Our Mission is to Improve the quality of lives of Children, Women, the Elderly and other Marginalized Vulnerable groups through Human Development and Interventions to Strengthen Communities.
Applications are invited for:
Title: Request for Proposals (RfP) for the Procurement of Psychotropic and PEP Medicines
Location: Old Airport, Sokoto
Request for Proposals for the Procurement of Psychotropic and PEP Medicines
Interested Bidders can quote for the items below:
|
Psychotropic & PEP Medicines |
||||
|
SN |
Medications |
Unit |
Quantity |
Expiry Date |
|
1 |
Amitriptyline (25 mg) |
Tablet (500) |
384 |
Not less than 14- 18 months from the date of supply.
|
|
2 |
Chlorpromazine (100 mg) |
Tablet (1000) |
384 |
|
|
3 |
Carbamazepine (200 mg) |
Tablet (1000) |
64 |
|
|
4 |
Haloperidol (5 mg) |
Tablet (1000) |
80 |
|
|
5 |
Fluoxetine (20 mg) |
Capsule (30) |
96 |
|
|
6 |
Tenofovir + Lamivudine + Dolutegravir (TLD) (300mg/300mg/50mg) |
Capsule (90) |
80 |
|
|
7 |
Azithromycin (250 mg) |
Capsule (6) |
192 |
|
|
8 |
Ceftriaxone (1g I.v) |
Pack (1 Vial) |
192 |
|
|
9 |
Metronidazole (400 mg) |
Tablet (10) |
96 |
|
|
10 |
Benzathine Penicillin (2.4 MU 1M Stat) |
Vials (10) |
80 |
|
|
11 |
Paracetamol (500 mg) |
Tablet (96) |
384 |
|
|
12 |
Povidone Iodine (Topical antiseptics) (2 litre) |
2-lliter Gallon |
96 |
|
|
13 |
Tetanus toxoid (0.5 ml) |
Ampoules (50) |
96 |
|
Albarka Health Spring Foundation (AHSF) kindly requests your quotation for the procurement of psychotropic and PEP medications as detailed in Annex 1 of this RFQ instruction.
This Request for Quotation comprises the following documents:
Section 2: RFQ Instructions and Data
|
Cost of preparation of |
AHSF shall not be responsible for any costs associated with a Supplier’s preparation |
|
Conflict of Interest |
AHSF encourages every prospective Supplier to avoid and prevent conflicts of interest by disclosing to AHSF if you, or any of your affiliates or personnel, were involved in the |
|
General Conditions of |
Any Purchase Order or contract that will be issued as a result of this RFQ shall be subject to the AHSF General Conditions of Contract for the provision of goods/services/transportation/medical services. |
|
Eligibility |
Bidders shall have the legal capacity to enter into a binding contract with AHSF and to deliver in the country, or through an authorized representative. |
|
Duties and taxes |
It is in AHSF's policy that withholding tax (WHT) shall be deducted from the total cost. |
|
Documents to be submitted |
Bidders shall include the following documents in their quotation:
|
|
Quotation validity period |
Quotations shall remain valid for 90 days from the deadline for the Submission of the Quotation. |
|
Price variation |
No price variation due to escalation, inflation, fluctuation in exchange rates, or any other market factors shall be accepted at any time during the validity of the quotation after the quotation has been received. |
|
Partial Quotes |
Not Permitted |
|
Payment Terms |
|
|
Contact Person for |
Focal Person: AHSF Procurement Department |
|
Clarifications |
Bidders are advised that requests for clarification will not be accepted within 2 days of the submission deadline. Responses to clarification requests will be emailed to the respective bidder. |
|
Evaluation criteria |
Full compliance with all requirements as specified Competitive and transparent pricing |
|
Right not to accept any |
AHSF is not bound to accept any quotation, nor award a contract or Purchase Order |
|
Right to vary requirements at the time of award |
At the time of award of the Contract or Purchase Order, AHSF reserves the right to vary (increase or decrease) the quantity of services and/or goods by up to a maximum of 25% of the total offer, without any change in the unit price or other terms and conditions. |
|
Type of Contract to be |
Purchase Order (PO) with respect to the accepted bids. |
|
Expected date for contract |
Not later than 19-October-26 |
|
Policies and procedures |
This RFQ is conducted in accordance with the Policies and Procedures of AHSF |
Annex I: Schdeule of Requirements
|
Delivery Requirements |
|
|
Delivery date and time |
Bidder shall deliver the service within 7 days after the Purchase Order (PO) is signed. |
|
Exact Address(es) of Delivery Location(s) |
Albarka Health Spring Foundation, [House No. 2, Road Safety Quarters, Old Airport, Sokoto State, Nigeria]. |
|
Warranty, After-sales service, and local service support requirements |
The Contractor remains responsible for the quality and condition of the supplies until they are certified and accepted by the inspection team provided by AHSF, after which a Goods Received Note (GRN) and a Certificate of Job Completion are issued. |
Evaluation Criteria
Preliminary Examination of Bids (Pass/Fail criteria):
|
Eligibility Requirement |
Document required |
Importance |
Criteria |
|
Annex 2: Quotation Submission Form duly completed and signed (and preferably stamped) |
Provide AHSF Quotation submission form (Annex 2) |
High |
Pass/Fail |
|
Annex 3: Financial Offer in line with the BOQ (Annex 1), duly completed and signed (and preferably stamped). |
Provide Annex 3 (Print out and fill) |
High |
Pass/Fail |
|
Evidence of registration with the Corporate Affairs Commission (CAC) |
Provide a valid CAC Certificate |
High |
Pass/Fail |
|
Valid MBBS, Pharmacy License, or Pharmaceutical Distribution License. |
Provide a valid MBBS, Pharmacy License, or Pharmaceutical Distribution License. |
High |
Pass/Fail |
|
Evidence of tax compliance |
Provide at least a 2025 Tax Clearance Certificate (TCC). |
High |
Pass/Fail |
Bidders must achieve a rating of "pass" in all categories to move forward to the technical assessment.
Technical Examination (Weighted criteria):
|
|
Criteria |
Requirement |
Rating |
|
A |
Similar experience: Successful similar experience in terms of equivalent nature and complexity carried out on behalf of hospitals, INGOs or NGOs, or other reputable organizations in Nigeria. |
Evidence of relevant experience supplying healthcare or pharmaceutical products within the last 2 years. |
35 Points |
|
|
|
|
|
|
|
Bidder must provide a copy of evidence, such as a Purchase Order, Contract, or Award Letter |
Note: No Submission will be scored a Zero |
|
|
B |
Financial Capability: Most recent audited financial statements and the ability to procure stock upfront. |
Audited financial statements (at least for 2024) |
25 Points |
|
|
|
Note: No Submission will be scored a Zero |
|
|
C |
Logistics & Delivery Capability: Lead-time commitments and best delivery options.
(A realistic delivery timeline is required as there will be penalties for timeline violation). |
If the service level is within the AHSF proposed delivery timeline.
|
20 Points |
|
|
|
Note: No Logistics & Delivery Capability will be scored a Zero |
|
|
D |
CVs of key Lead/Supervisory staff. |
Bachelor’s Degree in pharmacy, MBBS, and related fields with a minimum of 5 years’ experience and above in relevant activity. |
20 Points |
|
|
|
|
|
|
|
Required: |
|
|
|
|
A detailed CV should be presented showing the qualifications of all staff. |
|
|
|
|
A valid pharmacy license or pharmaceutical distribution license must accompany the CVs |
Note: No Submission will be scored a Zero |
|
Only bidders who achieve a technical evaluation score of 70% or higher will proceed to the financial evaluation phase.
Detailed Examination of Bids (Financial Examination):
Where Sc = St x T% + Sf x F%.:
Annex 2 (Quotation Submission Form)
Bidders are requested to download and complete this form, including the Company Profile and Bidder’s Declaration, sign it, and return it as part of their quotation along with Annex 3: Financial Offer.
The Bidder shall fill in this form following the instructions indicated. No alterations to its format shall be permitted, and no substitutions shall be accepted.
Download the RFQ: Click Here
Note:
Bidder`s Declaration of Conformity (Please tick Yes or No as applicable)
|
YES |
NO |
|
|
☐ |
☐ |
On behalf of the Supplier, I hereby represent and warrant that neither the Supplier, nor any person having powers of representation, decision-making, or control over it or any member of its administrative, management, or supervisory body, has been the subject of a final judgment or final administrative decision for one of the following reasons: bankruptcy, insolvency or winding-up procedures; breach of obligations relating to the payment of taxes or social security contributions; grave professional misconduct, including misrepresentation, fraud; corruption; conduct related to a criminal organization; money laundering or terrorist financing; terrorist offenses or offences linked to terrorist activities; child labour and another trafficking in human beings, any discriminatory or exploitative practice, or any practice that is inconsistent with the rights outlined in the Convention on the Rights of the Child or other prohibited practices; irregularity; creating or being a shell company. |
|
☐ |
☐ |
On behalf of the Supplier, I further represent and warrant that the Supplier is financially sound and duly licensed. |
|
☐ |
☐ |
On behalf of the Supplier, I further represent and warrant that the Supplier has adequate human resources, equipment, competence, expertise, and skills necessary to complete the contract fully and satisfactorily, within the stipulated completion period, and in accordance with the relevant terms and conditions. |
|
☐ |
☐ |
On behalf of the Supplier, I further represent and warrant that the Supplier complies with all applicable laws, ordinances, rules, and regulations. |
|
☐ |
☐ |
On behalf of the Supplier, I further represent and warrant that the Supplier will in all circumstances, act in the best interests of AHSF. |
|
☐ |
☐ |
On behalf of the Supplier, I further represent and warrant that no official of AHSF or any third party has received from, will be offered by, or will receive from the Supplier any direct or indirect benefit arising from the contract. |
|
☐ |
☐ |
On behalf of the Supplier, I further represent and warrant that the Supplier has not misrepresented or concealed any material facts during the contracting process. |
|
☐ |
☐ |
On behalf of the Supplier, I further represent and warrant that the Supplier will respect the legal status, privileges, and immunities of AHSF as an intergovernmental organization. |
|
☐ |
☐ |
On behalf of the Supplier, I further represent and warrant that neither the Supplier nor any persons having powers of representation, decision-making, or control over the Supplier or any member of its administrative, management, or supervisory body are included in the most recent Consolidated United Nations Security Council Sanctions List (the “UN Sanctions List”) or are the subject of any sanctions or other temporary suspension. The Supplier will immediately disclose to AHSF if it or they become subject to any sanction or temporary suspension. |
|
☐ |
☐ |
On behalf of the Supplier, I further represent and warrant that the Supplier does not employ, provide resources to, support, contract, or otherwise deal with any person, entity, or other group associated with terrorism as per the UN Sanctions List and any other applicable anti-terrorism legislation. |
|
☐ |
☐ |
On behalf of the Supplier, I further represent and warrant that the Supplier will apply the highest ethical standards, the principles of efficiency and economy, equal opportunity, open competition, and transparency, and will avoid any conflict of interest. |
|
☐ |
☐ |
It is the responsibility of the Supplier to inform AHSF immediately of any change to the information provided in this Declaration. |
|
☐ |
☐ |
On behalf of the Supplier, I certify that I am duly authorized to sign this Declaration and, on behalf of the Supplier, I agree to abide by the terms of this Declaration for the duration of any contract entered into between the Supplier and AHSF. |
|
☐ |
☐ |
AHSF reserves the right to terminate any contract between AHSF and the Supplier, with immediate effect and without liability, in the event of any misrepresentation made by the Supplier in this Declaration. |
Note: This form is mandatory to fill in and sign by every vendor who submits the quotation
Signature: _________________________________________________
Name: ____________________________________________________
Title: _____________________________________________________
Date: _____________________________________________________
Annex 3: Technical and Financial Offer - Works
Bidders are requested to complete this form, sign it, and return it as part of their quotation along with the Annex 2 Quotation Submission Form. The Bidder shall fill in this form following the instructions indicated. No alterations to its format shall be permitted, and no substitutions shall be accepted.
|
Name of Bidder: ________________________________________________________________________________
|
|
|
Address of Bidder: ____________________________________________ |
Date: ________________________ |
Financial Offer
|
Description of Works |
UOM |
Qty |
Cost |
|
Total Cost for the Purchase of Psychotropic & PEP Medicines |
Lumpsum |
1 |
|
Compliance with Requirements
|
You Responses |
|||
|
|
Yes, we will comply |
No, we cannot comply |
If you cannot comply, pls. indicate a counterproposal |
|
Delivery Lead Time |
☐ |
☐ |
|
|
NAFDAC certification/registration for all products offered |
☐ |
☐ |
|
|
Validity of Quotation |
☐ |
☐ |
|
|
Payment terms |
☐ |
☐ |
|
|
Above 18 Months shelve life for all products supplied |
☐ |
☐ |
|
I, the undersigned, certify that I am duly authorized to sign this quotation and bind the company below if the quotation is accepted.
|
The exact name and address of the company
|
Authorized Signature:
|
Appendix
Sample images of the drugs; they must be from a reputable manufacturer and be NAFDAC registered. Shelf-life must be above 18 months from the supply date.
Sample images of the drugs; they must be from a reputable manufacturer and be NAFDAC registered. Shelf-life must be above 18 months from the supply date.
|
PSYCHOTROPIC DRUG |
Some Recommended Manufacturers |
Samples |
||
|
Name |
Size |
Unit |
||
|
Amitriptyline |
25mg |
tablets |
AdvaCare Pharma, Apotex, LGM Pharma, Marcan Pharmaceuticals, Ecomed Pharma |
|
|
Chlorpromazine |
100mg |
tablets |
AdvaCare Pharma, Kreative Organics, Raks Pharma, and Biophore India |
|
|
Carbamazepine |
200mg |
tablets |
Sandoz (Canada), AdvaCare Pharma, CTX Lifesciences (API), Actiza Pharmaceutical, Chemidex Pharma, Essential Pharma, Ranbaxy, Novartis Pharmaceuticals |
|
|
Haloperidol |
5mg |
tablets |
Janssen Pharmaceutica, Vamsi Labs Limited (India), LGM Pharma (USA), Mankind Pharma (India), RPG Life Sciences (India), Flagship Biotech International (India) |
|
|
Fluoxetine |
20mg |
Capsule |
AdvaCare Pharma, Sandoz, Apnar Pharma, Aurobindo Pharma, Cadila Pharmaceuticals, Teva Pharmaceuticals, Shanxi Qianyuan Pharmaceutical |
|
|
PEP Drugs |
Recommended Manufacturers |
Samples Image |
||
|
Name |
Size |
Unit |
||
|
Tenofovir + Lamivudine + Dolutegravir (TLD) (300mg/300mg/50mg) |
(300mg/300mg/50mg) |
Capsule (90) |
Aurobindo Pharma, Laurus Labs, Emcure Pharmaceuticals, Strides Pharma Science, and Hetero Labs |
|
|
Levonorgestrel (1.5mg) |
(1.5mg) |
Tablet (1) |
Crescent Pharma, Omicron Pharma, AdvaCare Pharma, HLL Lifecare Ltd, Lupin Healthcare, Xiromed, and Montage Laboratories |
|
|
Azithromycin (250mg) |
(250mg) |
Tablet (6) |
Pfizer, Cipla Ltd, Aurobindo Pharma (Milpharm Ltd), Alembic Pharmaceuticals, Athene Chemicals, Therawin Formulations, and AstraEureka Pharmaceuticals. |
|
|
Ceftriaxone (1g I.v) |
(1g I.v) |
Vial |
Roche, Pfizer/Hospira, Sandoz, Cipla, Alkem Laboratories, Wockhardt UK Ltd, AdvaCare Pharma, Reyoung Pharmaceutical CO., LTD., MarleyShree Pharmaceutical Company, MC Foris Pharmaceuticals Limited, Kenneth Global Investment Pharmacy Limited, and Venus Remedies Ltd. |
|
|
Metronidazole (400mg) |
(400mg) |
Tablet (10) |
Unique Pharmaceuticals Limited, Sanofi, Aurobindo Pharma / Milpharm, Crescent Pharma, Sophia Pharmaceutical Company, Alphine Pharmaceuticals, Sun Pharma UK Ltd, Teva UK Ltd, Viatris UK Healthcare Ltd, and various, smaller, local manufacturers (e.g., in Bangladesh/India). |
|
|
Benzathine Penicillin (2.4 MU 1M Stat) |
(2.4 MU 1M Stat) |
Vial |
Ando Pharma, AdvaCare Pharma, Centurion Healthcare, Wellona Pharma, Lavina Pharma, North China Pharmaceutical |
|
|
Paracetamol (500mg) |
(500mg) |
Tablet (96) |
Unique Pharmaceuticals, Emzor Pharmaceutical, Sygen Pharmaceuticals, Funag Pharmaceutical, May & Baker, De-Shalom Pharmaceutical Lab, Shalina Healthcare |
|
|
Povidone Iodine (Topical antiseptics) |
|
(2litre) |
|
|
|
Tetanus toxoid (0.5ml) |
(0.5ml) |
Ampoules |
Amson Vaccines & Pharma, Dano Vaccines, GlaxoSmithKline, Serum Institute of India |
|
Application Closing Date
7th October 2026, 11:59 PM.
Method of Application
Interested and qualified bidders should submit their quotations to: ahsf.tenders@ahsfng.org and copy: ahsfprocurement.tenders@gmail.com .
Note
This is very important!
For physical submission of bids;
Hard copy submission can be done at the AHSF office located at:
House No.2, Road Safety Quarters,
Old Airport, Sokoto State, Nigeria.
Note: This must be in a sealed envelope, with all relevant documents.
When preparing your quotation, please refer to the RFQ Instructions and Data: